Financhill
Buy
63

CDRE Quote, Financials, Valuation and Earnings

Last price:
$35.38
Seasonality move :
12.96%
Day range:
$34.69 - $35.48
52-week range:
$27.07 - $40.28
Dividend yield:
1.03%
P/E ratio:
37.15x
P/S ratio:
2.58x
P/B ratio:
4.52x
Volume:
345.1K
Avg. volume:
330K
1-year change:
18.03%
Market cap:
$1.4B
Revenue:
$567.6M
EPS (TTM):
$0.95
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $404.6M $427.3M $457.8M $482.5M $567.6M
Revenue Growth (YoY) -3.83% 5.6% 7.15% 5.39% 17.62%
 
Cost of Revenues $251.7M $256.6M $282.2M $281.8M $334.1M
Gross Profit $152.9M $170.7M $175.7M $200.7M $233.5M
Gross Profit Margin 37.8% 39.95% 38.37% 41.6% 41.14%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $106.6M $115M $153.1M $140.5M $158.3M
Other Inc / (Exp) -$3.4M -$19.5M -$5.5M -$1.3M -$10.7M
Operating Expenses $97.3M $115.5M $154.6M $142M $160.7M
Operating Income $55.6M $55.1M $21.1M $58.7M $72.8M
 
Net Interest Expenses $24.4M $16.4M $6.2M $4.5M $7.8M
EBT. Incl. Unusual Items $27.9M $19.2M $9.4M $52.9M $54.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$10.6M $6.5M $3.6M $14.3M $18.1M
Net Income to Company $38.5M $12.7M $5.8M $38.6M $36.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $38.5M $12.7M $5.8M $38.6M $36.1M
 
Basic EPS (Cont. Ops) $1.15 $0.44 $0.16 $1.03 $0.90
Diluted EPS (Cont. Ops) $1.15 $0.44 $0.16 $1.02 $0.90
Weighted Average Basic Share $33.5M $28.6M $36.1M $37.5M $39.9M
Weighted Average Diluted Share $33.5M $28.6M $36.1M $37.9M $40.3M
 
EBITDA $67M $49.3M $31.2M $73.2M $78.5M
EBIT $52.3M $35.6M $15.6M $57.5M $62M
 
Revenue (Reported) $404.6M $427.3M $457.8M $482.5M $567.6M
Operating Income (Reported) $55.6M $55.1M $21.1M $58.7M $72.8M
Operating Income (Adjusted) $52.3M $35.6M $15.6M $57.5M $62M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $110.5M $104.4M $111.7M $137.9M $130.1M
Revenue Growth (YoY) 12.86% -5.55% 7.03% 23.37% -5.63%
 
Cost of Revenues $66.6M $64.2M $65.1M $80.2M $74M
Gross Profit $44M $40.2M $46.6M $57.6M $56.1M
Gross Profit Margin 39.77% 38.49% 41.72% 41.8% 43.14%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $28.1M $54M $35.3M $40.7M $41.8M
Other Inc / (Exp) -$365K -$804K $364K -$4.5M $589K
Operating Expenses $28.2M $54.1M $35.4M $42.6M $41.9M
Operating Income $15.8M -$13.9M $11.2M $15.1M $14.3M
 
Net Interest Expenses $5M $1.5M $1.6M $1.6M $2.2M
EBT. Incl. Unusual Items $10.3M -$16.2M $9.9M $8.9M $12.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.5M -$6M $2.9M $2M $3.4M
Net Income to Company $6.9M -$10.2M $7M $6.9M $9.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.9M -$10.2M $7M $6.9M $9.2M
 
Basic EPS (Cont. Ops) $0.21 -$0.30 $0.19 $0.18 $0.23
Diluted EPS (Cont. Ops) $0.21 -$0.30 $0.19 $0.18 $0.23
Weighted Average Basic Share $33.5M $34.4M $37.4M $37.9M $40.6M
Weighted Average Diluted Share $33.5M $34.4M $37.6M $38.6M $41M
 
EBITDA $18.9M -$11.1M $15.8M $14.5M $18.7M
EBIT $15.4M -$14.7M $11.6M $10.5M $14.8M
 
Revenue (Reported) $110.5M $104.4M $111.7M $137.9M $130.1M
Operating Income (Reported) $15.8M -$13.9M $11.2M $15.1M $14.3M
Operating Income (Adjusted) $15.4M -$14.7M $11.6M $10.5M $14.8M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $417.2M $421.2M $465.2M $508.6M $559.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $259.4M $254.2M $283.1M $296.9M $327.8M
Gross Profit $157.8M $166.9M $182.1M $211.7M $232M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $107.6M $140.9M $134.4M $146M $159.4M
Other Inc / (Exp) -$3.1M -$20M -$4.3M -$6.2M -$5.6M
Operating Expenses $98.3M $141.4M $135.9M $149.2M $160M
Operating Income $59.5M $25.5M $46.2M $62.6M $72M
 
Net Interest Expenses $22.8M $12.9M $6.4M $4.5M $8.4M
EBT. Incl. Unusual Items $33.7M -$7.3M $35.5M $51.9M $57.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$7.4M -$3M $12.5M $13.3M $19.5M
Net Income to Company $41.1M -$4.4M $23M $38.6M $38.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $41.1M -$4.4M $23M $38.6M $38.5M
 
Basic EPS (Cont. Ops) $1.23 -$0.13 $0.63 $1.02 $0.95
Diluted EPS (Cont. Ops) $1.23 -$0.13 $0.61 $1.01 $0.95
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $70.8M $19.3M $58.2M $71.8M $82.7M
EBIT $56.4M $5.5M $41.9M $56.4M $66.3M
 
Revenue (Reported) $417.2M $421.2M $465.2M $508.6M $559.8M
Operating Income (Reported) $59.5M $25.5M $46.2M $62.6M $72M
Operating Income (Adjusted) $56.4M $5.5M $41.9M $56.4M $66.3M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $110.5M $104.4M $111.7M $137.9M $130.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $66.6M $64.2M $65.1M $80.2M $74M
Gross Profit $44M $40.2M $46.6M $57.6M $56.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $28.1M $54M $35.3M $40.7M $41.8M
Other Inc / (Exp) -$365K -$804K $364K -$4.5M $589K
Operating Expenses $28.2M $54.1M $35.4M $42.6M $41.9M
Operating Income $15.8M -$13.9M $11.2M $15.1M $14.3M
 
Net Interest Expenses $5M $1.5M $1.6M $1.6M $2.2M
EBT. Incl. Unusual Items $10.3M -$16.2M $9.9M $8.9M $12.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.5M -$6M $2.9M $2M $3.4M
Net Income to Company $6.9M -$10.2M $7M $6.9M $9.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.9M -$10.2M $7M $6.9M $9.2M
 
Basic EPS (Cont. Ops) $0.21 -$0.30 $0.19 $0.18 $0.23
Diluted EPS (Cont. Ops) $0.21 -$0.30 $0.19 $0.18 $0.23
Weighted Average Basic Share $33.5M $34.4M $37.4M $37.9M $40.6M
Weighted Average Diluted Share $33.5M $34.4M $37.6M $38.6M $41M
 
EBITDA $18.9M -$11.1M $15.8M $14.5M $18.7M
EBIT $15.4M -$14.7M $11.6M $10.5M $14.8M
 
Revenue (Reported) $110.5M $104.4M $111.7M $137.9M $130.1M
Operating Income (Reported) $15.8M -$13.9M $11.2M $15.1M $14.3M
Operating Income (Adjusted) $15.4M -$14.7M $11.6M $10.5M $14.8M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $2.9M $33.9M $45.3M $87.7M $124.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $43.6M $48.3M $64.6M $58.4M $93.5M
Inventory $60.9M $64M $70.3M $81M $82.4M
Prepaid Expenses $6.7M $10.4M $10.1M $11.9M $19M
Other Current Assets $3.4M $3.2M $6.8M $6.9M $7.7M
Total Current Assets $117.5M $160M $197M $245.8M $327.6M
 
Property Plant And Equipment $35.4M $33.1M $53.8M $51.2M $60.7M
Long-Term Investments -- -- -- -- --
Goodwill $66.3M $66.3M $81.6M $81.7M $148.2M
Other Intangibles $51M $42.4M $50.7M $43.5M $107.5M
Other Long-Term Assets $150K $3M $6.6M $5M $4.2M
Total Assets $283.3M $311.8M $392M $431.2M $652.7M
 
Accounts Payable $22M $19.3M $23.4M $28.4M $29.6M
Accrued Expenses $10M $8.9M $8.6M $11.3M $12.9M
Current Portion Of Long-Term Debt $3.5M $13.2M $12.2M $12.3M $11.4M
Current Portion Of Capital Lease Obligations -- -- $3.8M $3.5M $4.8M
Other Current Liabilities -- $128K -- -- --
Total Current Liabilities $62.5M $74.6M $78.9M $95.2M $94.1M
 
Long-Term Debt $209.3M $146.5M $137.5M $127.8M $211.8M
Capital Leases -- -- -- -- --
Total Liabilities $274.4M $223.2M $226.1M $234M $341.2M
 
Common Stock $3K $3K $4K $4K $4K
Other Common Equity Adj -$2.9M -$1.9M $2.1M $634K -$1.4M
Common Equity $8.9M $88.6M $165.9M $197.2M $311.5M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $8.9M $88.6M $165.9M $197.2M $311.5M
 
Total Liabilities and Equity $283.3M $311.8M $392M $431.2M $652.7M
Cash and Short Terms $2.9M $33.9M $45.3M $87.7M $124.9M
Total Debt $212.8M $159.7M $149.7M $140.1M $223.2M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $17.4M $9.9M $48.3M $87.1M $133.4M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $49.3M $52M $55.7M $68.1M $82.9M
Inventory $63.5M $69.4M $76.3M $95.8M $91.8M
Prepaid Expenses $7.4M $7.7M $11.8M $12.4M $17M
Other Current Assets $2.4M $4.4M $6.4M $6M $7.4M
Total Current Assets $140.1M $143.7M $198.5M $269.3M $332.5M
 
Property Plant And Equipment $34.9M $35.7M $52.8M $56.7M $60.7M
Long-Term Investments -- -- -- -- --
Goodwill $66.3M $72.5M $81.3M $148.9M $148.6M
Other Intangibles $49M $50.2M $48.8M $115M $105.9M
Other Long-Term Assets $420K $6M $5.3M $5.5M $4M
Total Assets $300.5M $321M $389M $599.4M $656.3M
 
Accounts Payable $27.2M $27.5M $27.3M $30.3M $32.1M
Accrued Expenses $40.1M $34.4M $32.9M $47.5M $41.6M
Current Portion Of Long-Term Debt $2.6M $11.7M $11.1M $15.2M $11.4M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- $120K -- -- --
Total Current Liabilities $71.2M $75.9M $75.4M $95.6M $93.7M
 
Long-Term Debt $209.3M $144.7M $135.1M $200.6M $209.1M
Capital Leases -- -- -- -- --
Total Liabilities $284.5M $225.1M $219.5M $328.7M $338.7M
 
Common Stock $3K $3K $4K $4K $4K
Other Common Equity Adj -$2.6M $931K $1.7M $988K -$1.5M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $16M $95.9M $169.5M $270.7M $317.6M
 
Total Liabilities and Equity $300.5M $321M $389M $599.4M $656.3M
Cash and Short Terms $17.4M $9.9M $48.3M $87.1M $133.4M
Total Debt $211.9M $156.4M $146.2M $215.8M $220.5M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $38.5M $12.7M $5.8M $38.6M $36.1M
Depreciation & Amoritzation $14.7M $13.7M $15.7M $15.7M $16.4M
Stock-Based Compensation -- $355K $31.9M $9.4M $8.4M
Change in Accounts Receivable $11.8M -$4.6M -$11.5M $6.6M -$24.9M
Change in Inventories $1.6M -$3.2M $1.2M -$10.2M $10M
Cash From Operations $45.4M $40.1M $46.4M $73.2M $31.8M
 
Capital Expenditures $4.7M $2.8M $4.5M $6.7M $5.7M
Cash Acquisitions -- -- -$55.5M -- -$141.8M
Cash From Investing $19.8M -$2.8M -$59.6M -$6.5M -$147.4M
 
Dividends Paid (Ex Special Dividend) -- -$12.8M -$11.5M -$12M -$13.9M
Special Dividend Paid
Long-Term Debt Issued $604.4M $461.7M $47M $3.9M $134.9M
Long-Term Debt Repaid -$660.7M -$527.7M -$58.1M -$14M -$51M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$8.6M -$11.3M -$9.3M -$2.7M -$9.1M
Cash From Financing -$64.9M -$6.6M $24.5M -$24.7M $152.7M
 
Beginning Cash (CF) $2.5M $2.9M $33.9M $45.3M $87.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $301K $30.7M $11.2M $42M $37M
Ending Cash (CF) $2.9M $33.9M $45.3M $87.7M $124.9M
 
Levered Free Cash Flow $40.7M $37.3M $41.9M $66.5M $26.1M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $6.9M -$10.2M $7M $6.9M $9.2M
Depreciation & Amoritzation $3.5M $3.5M $4.3M $3.9M $3.9M
Stock-Based Compensation -- $23.6M $2.7M $2.1M $2M
Change in Accounts Receivable -$5.6M -$1.7M $9.1M $2.7M $10.6M
Change in Inventories -$2.5M -$3M -$5.8M $1.8M -$9.1M
Cash From Operations $16.8M $8.9M $12.7M $2.1M $17.4M
 
Capital Expenditures $788K $950K $781K $1.3M $1.3M
Cash Acquisitions -- -$19.8M -- -$141.3M --
Cash From Investing -$788K -$20.7M -$580K -$142.6M -$1.3M
 
Dividends Paid (Ex Special Dividend) -- -$2.8M -$3M -$3.3M -$3.9M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $88.6M -- -- $85.5M --
Long-Term Debt Repaid -$89.2M -$2.5M -$2.5M -$8M -$2.8M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$917K -$7.7M -$3.8M -$8M -$1.1M
Cash From Financing -$1.5M -$13M -$9.3M $139.8M -$7.8M
 
Beginning Cash (CF) $2.9M $33.9M $45.3M $87.7M $124.9M
Foreign Exchange Rate Adjustment $13K $798K $169K $74K $228K
Additions / Reductions $14.6M -$24.8M $2.8M -$713K $8.3M
Ending Cash (CF) $17.4M $9.9M $48.3M $87.1M $133.4M
 
Levered Free Cash Flow $16M $8M $11.9M $794K $16.1M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $41.1M -$4.4M $23M $38.6M $38.5M
Depreciation & Amoritzation $14.4M $13.7M $16.4M $15.4M $16.3M
Stock-Based Compensation -- $23.9M $11M $8.7M $8.3M
Change in Accounts Receivable -$2.3M -$708K -$768K $223K -$17M
Change in Inventories $3M -$3.6M -$1.7M -$2.6M -$942K
Cash From Operations $47.4M $32.2M $50.2M $62.6M $47M
 
Capital Expenditures $4.2M $3M $4.3M $7.3M $5.6M
Cash Acquisitions -- -$19.8M -$35.8M -$141.3M -$520K
Cash From Investing $14.7M -$22.8M -$39.5M -$148.6M -$6.1M
 
Dividends Paid (Ex Special Dividend) -- -$15.5M -$11.7M -$12.3M -$14.5M
Special Dividend Paid
Long-Term Debt Issued $582.1M -- $47M $89.4M $49.4M
Long-Term Debt Repaid -$647.6M -$441M -$58.1M -$19.5M -$45.8M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$8.7M -$18.1M -$5.4M -$6.8M -$2.2M
Cash From Financing -$74.2M -$18.1M $28.1M $124.4M $5.1M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$12.1M -$8.7M $38.9M $38.4M $46M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $43.1M $29.2M $45.9M $55.3M $41.4M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $6.9M -$10.2M $7M $6.9M $9.2M
Depreciation & Amoritzation $3.5M $3.5M $4.3M $3.9M $3.9M
Stock-Based Compensation -- $23.6M $2.7M $2.1M $2M
Change in Accounts Receivable -$5.6M -$1.7M $9.1M $2.7M $10.6M
Change in Inventories -$2.5M -$3M -$5.8M $1.8M -$9.1M
Cash From Operations $16.8M $8.9M $12.7M $2.1M $17.4M
 
Capital Expenditures $788K $950K $781K $1.3M $1.3M
Cash Acquisitions -- -$19.8M -- -$141.3M --
Cash From Investing -$788K -$20.7M -$580K -$142.6M -$1.3M
 
Dividends Paid (Ex Special Dividend) -- -$2.8M -$3M -$3.3M -$3.9M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $88.6M -- -- $85.5M --
Long-Term Debt Repaid -$89.2M -$2.5M -$2.5M -$8M -$2.8M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$917K -$7.7M -$3.8M -$8M -$1.1M
Cash From Financing -$1.5M -$13M -$9.3M $139.8M -$7.8M
 
Beginning Cash (CF) $2.9M $33.9M $45.3M $87.7M $124.9M
Foreign Exchange Rate Adjustment $13K $798K $169K $74K $228K
Additions / Reductions $14.6M -$24.8M $2.8M -$713K $8.3M
Ending Cash (CF) $17.4M $9.9M $48.3M $87.1M $133.4M
 
Levered Free Cash Flow $16M $8M $11.9M $794K $16.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Why Mobileye Might Be Wall Street’s Next Big Surprise
Why Mobileye Might Be Wall Street’s Next Big Surprise

The trend to automate vehicles started long ago when adding…

Why Is Rigetti Stock Going Up?
Why Is Rigetti Stock Going Up?

Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
81
SMLR alert for May 19

Semler Scientific [SMLR] is up 5.85% over the past day.

Sell
25
GLOB alert for May 19

Globant SA [GLOB] is up 4.02% over the past day.

Buy
94
HIMS alert for May 19

Hims & Hers Health [HIMS] is down 3.57% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock